- Home
- APLT vs IMOS Comparison
APLT vs IMOS Comparison
Compare APLT & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLT | IMOS |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 980.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLT | IMOS |
|---|---|---|
| Price | $0.11 | $30.25 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.25 | N/A |
| AVG Volume (30 Days) | ★ 9.9M | 12.5K |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $1,000,000.00 | ★ $748,307,671.00 |
| Revenue This Year | $124.18 | $5.78 |
| Revenue Next Year | $66.67 | $10.84 |
| P/E Ratio | ★ N/A | $135.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.10 | $12.78 |
| 52 Week High | $1.50 | $30.98 |
Technical Indicators
Market Signals| Indicator | APLT | IMOS |
|---|---|---|
| Relative Strength Index (RSI) | 25.98 | 65.83 |
| Support Level | $0.10 | $28.20 |
| Resistance Level | $0.13 | $29.12 |
| Average True Range (ATR) | 0.02 | 0.61 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 7.66 | 91.97 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.